Bispecific antibodies poised to deliver wave of cancer therapies

Nat Biotechnol. 2021 Mar;39(3):251-254. doi: 10.1038/s41587-021-00850-6.

Cormac Sheridan ¹

Affiliations

Affiliation

1 , Dublin, Ireland.

PMID: 33692520 DOI: 10.1038/s41587-021-00850-6

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-P99814

Pavurutamab

Bispecific T-cell Engager

CD3

Inflammation/Immunology; Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2024 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us